Screener
Denali Therapeutics Inc. DNLI Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s asset turnover?
- Denali Therapeutics Inc. (DNLI) reported asset turnover of 0× in Q4 2024.
- How has Denali Therapeutics Inc.'s asset turnover changed year-over-year?
- Denali Therapeutics Inc.'s asset turnover decreased by 100.0% year-over-year, from 0.3× to 0×.
- What is the long-term trend for Denali Therapeutics Inc.'s asset turnover?
- Over 4 years (2020 to 2024), Denali Therapeutics Inc.'s asset turnover has grown at a -100.0% compound annual growth rate (CAGR), from 0.3× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Denali Therapeutics Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude